Volume 62, Issue 4

Search all Cancer Chemotherapy and Pharmacology articles

September 2008

Filter by

Volume:

Sort by

Date published:

New to old Old to new

21 articles in this issue

Anti-microtubule activity of tubeimoside I and its colchicine binding site of tubulin
Rundi Ma
Gang Song
Tingxi Yu
Original Article Open access 21 November 2007 Pages: 559 - 568
c-Jun-NH₂-terminal kinase potentiates apoptotic cell death in response to carboplatin in B lymphoma cells
Eiko Takada
Kikumi Hata
Junichiro Mizuguchi
Original Article 17 November 2007 Pages: 569 - 576
Factors affecting sensitivity to antitumor platinum derivatives of human colorectal tumor cell lines
Noriaki Kitada
Kohji Takara
Teruyoshi Yokoyama
Original Article 21 November 2007 Pages: 577 - 584
Effect of pure curcumin, demethoxycurcumin, and bisdemethoxycurcumin on WT1 gene expression in leukemic cell lines
Songyot Anuchapreeda
Singkome Tima
Pornngarm Limtrakul
Original Article 23 November 2007 Pages: 585 - 594
Biological properties of 4-methyl-2,7-diamino-5,10-diphenyl-4,9-diazapyrenium hydrogensulfate (ADAP)
Saška Marczi
Ljubica Glavaš-Obrovac
Mladen Žinić
Original Article 23 November 2007 Pages: 595 - 604
Inhibition by erlotinib of primary lung adenocarcinoma at an early stage in male mice
Laura K. Zerbe
Lori D. Dwyer-Nield
Alvin M. Malkinson
Original Article 21 November 2007 Pages: 605 - 620
Antitumour effect of combination treatment with Sabarubicin (MEN 10755) and cis-platin (DDP) in human lung tumour xenograft
M. Bigioni
A. Benzo
M. Binaschi
Original Article 24 November 2007 Pages: 621 - 629
A phase I safety, pharmacological, and biological study of the farnesyl protein transferase inhibitor, lonafarnib (SCH 663366), in combination with cisplatin and gemcitabine in patients with advanced solid tumors
Laura Q. M. Chow
S. Gail Eckhardt
Lia Gore
Original Article 06 December 2007 Pages: 631 - 646
Intraperitoneal gemcitabine pharmacokinetics: a pilot and pharmacokinetic study in patients with advanced adenocarcinoma of the pancreas
T. Clark Gamblin
Merrill J. Egorin
David L. Bartlett
Original Article 27 November 2007 Pages: 647 - 653
Pharmacokinetics of oral fenretinide in neuroblastoma patients: indications for optimal dose and dosing schedule also with respect to the active metabolite 4-oxo-fenretinide
Franca Formelli
Elena Cavadini
Stefano Persiani
Original Article 08 December 2007 Pages: 655 - 665
Tailored preoperative treatment of locally advanced triple negative (hormone receptor negative and HER2 negative) breast cancer with epirubicin, cisplatin, and infusional fluorouracil followed by weekly paclitaxel
Rosalba Torrisi
Alessandra Balduzzi
Marco Colleoni
Original Article 07 December 2007 Pages: 667 - 672
A multi-centre retrospective review of second-line therapy in advanced pancreatic adenocarcinoma
M. Reni
R. Berardi
S. Grisanti
Original Article 03 January 2008 Pages: 673 - 678
Pharmacokinetics of heated intraperitoneal oxaliplatin
G. Ferron
S. Dattez
E. Chatelut
Original Article 15 December 2007 Pages: 679 - 683
Cisplatin, gemcitabine and treosulfan is effective in chemotherapy-pretreated relapsed stage IV uveal melanoma patients
Jens Atzpodien
Kerstin Terfloth
Martina Reitz
Original Article 15 December 2007 Pages: 685 - 688
BRCA1 modulates sensitivity to 5F-203 by regulating xenobiotic stress-inducible protein levels and EROD activity
Hyo Jin Kang
Hee Jeong Kim
Insoo Bae
Original Article 12 December 2007 Pages: 689 - 697
Molecular predictors of human nervous system cancer responsiveness to enediyne chemotherapy
Danny Rogers
Karen D. Nylander
Nina F. Schor
Original Article 13 March 2008 Pages: 699 - 706
Delineation of the interactions between the chemotherapeutic agent eribulin mesylate (E7389) and human CYP3A4
Z.-Y. Zhang
B. M. King
Y. N. Wong
Original Article 23 April 2008 Pages: 707 - 716
Impact of celecoxib on capecitabine tolerability and activity in pretreated metastatic breast cancer: results of a phase II study with biomarker evaluation
Alessandra Fabi
Giulio Metro
Francesco Cognetti
Clinical Trial Report 06 December 2007 Pages: 717 - 725
A phase I trial of gemcitabine in combination with patupilone in patients with advanced solid tumors
William Schelman
Sherry Morgan-Meadows
George Wilding
Clinical Trial Report 03 January 2008 Pages: 727 - 733
Imatinib inhibition of fludarabine uptake in T-lymphocytes
Erica L. Woodahl
Joanne Wang
Jeannine S. McCune
Short Communication 15 November 2007 Pages: 735 - 739
Prompt and sustained response of a steroid-refractory autoimmune hemolytic anemia to a rituximab-based therapy in a chronic lymphocytic leukemia patient
Massimo Gentile
Eugenio Lucia
Fortunato Morabito
Short Communcation 07 December 2007 Pages: 741 - 743

Volume 62, Issue 4

Anti-microtubule activity of tubeimoside I and its colchicine binding site of tubulin

c-Jun-NH₂-terminal kinase potentiates apoptotic cell death in response to carboplatin in B lymphoma cells

Factors affecting sensitivity to antitumor platinum derivatives of human colorectal tumor cell lines

Effect of pure curcumin, demethoxycurcumin, and bisdemethoxycurcumin on WT1 gene expression in leukemic cell lines

Biological properties of 4-methyl-2,7-diamino-5,10-diphenyl-4,9-diazapyrenium hydrogensulfate (ADAP)

Inhibition by erlotinib of primary lung adenocarcinoma at an early stage in male mice

Antitumour effect of combination treatment with Sabarubicin (MEN 10755) and cis-platin (DDP) in human lung tumour xenograft

A phase I safety, pharmacological, and biological study of the farnesyl protein transferase inhibitor, lonafarnib (SCH 663366), in combination with cisplatin and gemcitabine in patients with advanced solid tumors

Intraperitoneal gemcitabine pharmacokinetics: a pilot and pharmacokinetic study in patients with advanced adenocarcinoma of the pancreas

Pharmacokinetics of oral fenretinide in neuroblastoma patients: indications for optimal dose and dosing schedule also with respect to the active metabolite 4-oxo-fenretinide

Tailored preoperative treatment of locally advanced triple negative (hormone receptor negative and HER2 negative) breast cancer with epirubicin, cisplatin, and infusional fluorouracil followed by weekly paclitaxel

A multi-centre retrospective review of second-line therapy in advanced pancreatic adenocarcinoma

Pharmacokinetics of heated intraperitoneal oxaliplatin

Cisplatin, gemcitabine and treosulfan is effective in chemotherapy-pretreated relapsed stage IV uveal melanoma patients

BRCA1 modulates sensitivity to 5F-203 by regulating xenobiotic stress-inducible protein levels and EROD activity

Molecular predictors of human nervous system cancer responsiveness to enediyne chemotherapy

Delineation of the interactions between the chemotherapeutic agent eribulin mesylate (E7389) and human CYP3A4

Impact of celecoxib on capecitabine tolerability and activity in pretreated metastatic breast cancer: results of a phase II study with biomarker evaluation

A phase I trial of gemcitabine in combination with patupilone in patients with advanced solid tumors

Imatinib inhibition of fludarabine uptake in T-lymphocytes

Prompt and sustained response of a steroid-refractory autoimmune hemolytic anemia to a rituximab-based therapy in a chronic lymphocytic leukemia patient

Navigation